Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
about
Understanding migraine: Potential role of neurogenic inflammationThe pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraineEletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent responseThe anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigsMigraine: new molecular mechanisms.Neurogenic inflammation in the context of migraine.New migraine and pain research.Clinical pharmacology of the serotonin receptor agonist, zolmitriptan.Distribution of 5-HT1F Receptors in Monkey Vestibular and Trigeminal Ganglion Cells.Migraine: an overview.Animal models of headache: from bedside to bench and back to bedside.5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?Update on future headache treatments.Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.Animal migraine models for drug development: status and future perspectives.Lasmiditan for the treatment of migraine.Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.Pathophysiology of Migraine: A Disorder of Sensory Processing.Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT(1B) and 5-HT(1D) receptor antagonists and in situ hybridization.Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2.Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.Targeted 5-HT1F Therapies for Migraine.Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice
P2860
Q26747000-E1B34A11-0E5B-4BFD-8BDE-F840D0264020Q27008834-E8901251-036A-4B0C-ADAB-E255B3A1223BQ28074159-CEF01882-14DF-49BB-86B8-54C145BD44CFQ28345449-C2702F29-6C03-41BE-A59E-657F20104190Q33220839-7E24F8EC-BDFD-4E0B-A222-0D5C0ABE3163Q34218309-CEA8990D-A295-4F26-8554-24469E3C485CQ36787453-BCB4CC7E-86F8-4C2F-97C2-862F625BC806Q37008907-0B507123-C88F-4C18-8AFB-21D28C4A938FQ37323725-26E3D995-BDAD-405E-A9C1-F84523BAE971Q37627183-C3166939-3758-450A-B6EE-81C85F499BFCQ37699421-9688148B-C92D-411B-863F-D17C264F4F2AQ37739587-41FB1112-BA7D-4909-A603-498925430A05Q38108486-CEDA6A37-C924-4F67-BE0D-02872BC21EF7Q38129436-C5F4D3B7-3F3F-4964-8BDC-E17B04A00262Q38162801-358ABB04-FAB9-4ACD-B1F7-A739562279D5Q38771819-F28542BC-CA2F-404E-9B0C-BF4AAEF57689Q39012465-0D03E95C-05FB-4F0A-B07A-CB581FBD5C58Q39127073-33AE049F-E2EA-454D-8F13-C82A29BFC2D6Q43969535-6DEAFA28-CAF8-4540-9120-5F63B4B7841FQ43969540-45D61C1E-6B1C-4143-895E-BB14BF0186A5Q43981823-378AB4B0-74CF-415D-A03B-5244D643EBCDQ44057665-F5970928-CBB9-49E3-8AA5-7810802C3EBFQ52682101-7BD45BB5-3531-4FD0-8D88-F18A9E448DECQ57481750-BCB7454C-FB9F-4962-ABA9-D35C72D38120
P2860
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@ast
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@en
type
label
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@ast
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@en
prefLabel
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@ast
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.
@en
P2093
P2860
P1433
P1476
Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370
@en
P2093
D Williamson
M Cumberbatch
R Hargreaves
S Shepheard
P2860
P304
P356
10.1046/J.1468-2982.1999.1910851.X
P407
P577
1999-12-01T00:00:00Z